Alcon AG ALC-CH:Swiss Exchange

*Data is delayed | CHF
Last | 05/07/21 CEST
64.24quote price arrow up+9.24 (+16.80%)
Volume
1,334,930
52 week range
47.53 - 70.34

...

Loading . . .
  • Open62.88
  • Day High64.44
  • Day Low62.26
  • Prev Close55.00
  • 52 Week High70.34
  • 52 Week High Date04/29/21
  • 52 Week Low47.53
  • 52 Week Low Date05/04/20

Key Stats

  • Market Cap34,534.26M
  • Shares Out489.2M
  • 10 Day Average Volume1.01M
  • Dividend0.10
  • Dividend Yield0.16%
  • Beta0.08
  • YTD % Change9.18

KEY STATS

  • Open62.88
  • Day High64.44
  • Day Low62.26
  • Prev Close55.00
  • 52 Week High70.34
  • 52 Week High Date04/29/21
  • 52 Week Low47.53
  • 52 Week Low Date05/04/20
  • Market Cap34,534.26M
  • Shares Out489.2M
  • 10 Day Average Volume1.01M
  • Dividend0.10
  • Dividend Yield0.16%
  • Beta0.08
  • YTD % Change9.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.75
  • P/E (TTM)-85.65
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alcon AG

There is no recent news for this security.

Profile

MORE
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular...
F. Michael Ball
Chairman
D. Keith Grossman
Vice Chairman
David Endicott
Chief Executive Officer
Timothy Stonesifer
Chief Financial Officer
Address
Rue Louis-d'Affry 6
Fribourg
1701
Switzerland